Hormesis challenges the existing hazard-assessment process underlying environmental regulations, Calabrese says.

卡兹也说，激效挑战了现行做为环境管理依据的有质评估序。

But Calabrese suspects that in many cases, the benefits of hormesis may occur at levels higher than the recommended safe doses for humans.

但卡兹猜测，许多案例中，当浓度高于人体建议安全剂量时，激效才可能发挥效益。